Prevalence and Progression of Diabetic Retinopathy in a Tertiary Care Setting: An Initial Review With Recommended Screening Protocols

被引:0
|
作者
Mahar, Pir Salim [1 ,2 ]
Monis, Mohammad Daniyal [1 ]
Khan, Muhammad Fahadullah [1 ]
Ahsan, Shahid [1 ,3 ]
Memon, M. Saleh [1 ]
机构
[1] Isra Postgrad Inst Ophthalmol, Ophthalmol, Karachi, Pakistan
[2] Aga Khan Univ Hosp, Ophthalmol, Karachi, Pakistan
[3] Jinnah Med & Dent Coll, Biochem, Karachi, Pakistan
关键词
non-proliferative diabetic retinopathy; vision screening; proliferative diabetic retinopathy; diabetic macular edema; diabetes mellitus; VARIABILITY; HBA1C;
D O I
10.7759/cureus.69296
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: The objective of this study is to evaluate diabetic patients with either normal fundus or non- proliferative diabetic retinopathy (NPDR) changes, examine retinal alterations during follow-up, and propose follow-up guidelines within a tertiary eye care setting. Methods: A five-year prospective longitudinal study is being conducted at the Diabetic Clinic of Al Ibrahim Eye Hospital/Isra Postgraduate Institute of Ophthalmology, Karachi. Induction for the research took place from October 2021 to March 2022, and a two-year preliminary report is presented here. Newly diagnosed type II diabetic patients with normal fundus or NPDR of any stage, irrespective of age, gender, or glycemic status, who were willing to participate and agreed to follow-ups, were included. Patients with proliferative diabetic retinopathy (PDR), diabetic macular edema (DME), fundus non-visibility, or systemic complications of diabetes were excluded. Results: A total of 251 patients were enrolled, consisting of 80 individuals with a normal fundus and 171 with different stages of NPDR, including mild (N=59), moderate (N=91), and severe (N=21) retinopathy. The incidence of progression from mild to moderate NPDR was noted to be 52.5%, with a median time of 3.5 months. Progression from moderate to severe NPDR occurred in 37.1% of cases, with a median time of 4.5 months. Similarly, DME developed in 5% of patients with mild NPDR over eight months, in 22.2% with moderate NPDR over seven months, and in 37.5% with severe NPDR over 4.4 months. Conclusion: This study emphasizes the urgent need to revise diabetic retinopathy (DR) monitoring protocols for our Pakistani (Southeast Asian) population. The rapid progression of NPDR and the high rates of DME development demand more frequent screenings. Current guidelines recommending annual screenings are inadequate. Biannual screenings for patients with a normal fundus or mild NPDR, and quarterly assessments for those with moderate or severe NPDR, are necessary.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Artificial intelligence for diabetic retinopathy screening: a review
    Grzybowski, Andrzej
    Brona, Piotr
    Lim, Gilbert
    Ruamviboonsuk, Paisan
    Tan, Gavin S. W.
    Abramoff, Michael
    Ting, Daniel S. W.
    EYE, 2020, 34 (03) : 451 - 460
  • [42] A systematic review of diabetic retinopathy screening intervals
    Drinkwater, Jocelyn J.
    Kalantary, Amy
    Turner, Angus W.
    ACTA OPHTHALMOLOGICA, 2024, 102 (04) : e473 - e484
  • [44] Automated Screening for Diabetic Retinopathy - A Systematic Review
    Norgaard, Mads Fonager
    Grauslund, Jakob
    OPHTHALMIC RESEARCH, 2018, 60 (01) : 9 - 17
  • [45] SCREENING FOR DIABETIC-RETINOPATHY IN THE FAMILY-PRACTICE SETTING
    HILLIS, A
    DIECKERT, JP
    DAVIS, RD
    COUCHMAN, GR
    CRYAR, AK
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1993, 34 (04) : 1182 - 1182
  • [46] Optimal screening schedules for disease progression with application to diabetic retinopathy
    Bebu, Ionut
    Lachin, John M.
    BIOSTATISTICS, 2018, 19 (01) : 1 - 13
  • [47] Clinical Predictors of Diabetic Retinopathy Progression; A Systematic Review
    Al Ghamdi, Abdul Hamid
    CURRENT DIABETES REVIEWS, 2020, 16 (03) : 242 - 247
  • [48] Prevalence of diabetic retinopathy (DR) and association with metabolic parameters in the all Wales diabetic retinopathy screening programme
    Luzio, S. D.
    Dunstan, F. D.
    Owens, D. R.
    Thomas, R. L.
    Peter, R.
    DIABETIC MEDICINE, 2015, 32 : 191 - 191
  • [49] Development and Validation of an Automated AI-based Diabetic Retinopathy Screening Tool for Primary Care Setting
    Bhuiyan, Alauddin
    Govindaiah, Arun
    Hossain, Mohd
    Smith, R. Theodore
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (07)
  • [50] Diabetic retinopathy screening in urban primary care setting with a handheld smartphone-based retinal camera
    Márcia Silva Queiroz
    Jacira Xavier de Carvalho
    Silvia Ferreira Bortoto
    Mozania Reis de Matos
    Cristiane das Graças Dias Cavalcante
    Elenilda Almeida Silva Andrade
    Maria Lúcia Correa-Giannella
    Fernando Korn Malerbi
    Acta Diabetologica, 2020, 57 : 1493 - 1499